02.05.2012
- Biogen's quarterly profit fell short of analysts' estimates on weak sales of its Avonex multiple sclerosis treatment, its biggest-selling product. But the biotechnology company...
28.04.2012
- French drugmaker Sanofi posted better-than-expected quarterly results, bolstered by strong emerging markets, breaking with a trend of earnings misses by European rivals AstraZeneca...
27.04.2012
- Pharmaceutical firm Shire posted a 20% rise in first-quarter earnings on Thursday, just beating market expectations, as its drugs to treat hyperactivity again lifted market share...
26.04.2012
- Financier Carl Icahn said he has voluntarily dismissed a lawsuit filed against Amylin Pharmaceuticals after talking with the biotech company's chief executive, Daniel Bradbury...
25.04.2012
- U.S. biotech company Amgen is to buy Turkey's Mustafa Nevzat Pharmaceuticals, a maker of injectable generic drugs, for around $700 million in a deal underscoring Western drugmakers...
24.04.2012
- A new biotech corn developed by Dow AgroSciences could answer the prayers of U.S. farmers plagued by a fierce epidemic of super-weeds. Or it could trigger a flood of dangerous...
23.04.2012
- AstraZeneca has agreed to buy U.S. company Ardea Biosciences for $1.26 billion, giving it a new gout drug to bolster its weak pipeline in a deal that feeds a wave of M&A in the...
23.04.2012
- Australian flu drug maker Biota Holdings has agreed to take over U.S. firm Nabi Biopharmaceuticals to create a $258 million group and move to the United States, where investors...
19.04.2012
- Europe's largest biotech company Actelion said it expects results of a key late-stage trial on heart and lung disease drug macitentan in the next few weeks after a strong Swiss...
